blood coagulation factor

Chinese low-dose oral contraceptive and blood coagulation factor changes and factor ⅴ leiden mutation

口服避孕药与凝血因子的变化及因子Ⅴ基因突变的关系

An experimental study of the correlation of blood coagulation factor ⅷ - related antigen and blood flow at the fracture ends

骨折端Ⅷ因子相关抗原与血流量的实验研究

Identification of two novel mutations of human blood coagulation factor ⅴ gene in a Chinese family with congenital factor ⅴ deficiency

一个遗传性凝血因子Ⅴ缺乏症家系中凝血因子Ⅴ基因两种新突变的鉴定

Meanwhile , ameliorating hypoxia , using proper anticoagulant and supplying blood coagulation factor would help homeostatic function recovery .

改善缺氧，适当适时应用抗凝药物和补充凝血因子有助于止血功能的恢复。

Blood coagulation factor of asphyxia preterm infant and comprison of prior and post treatment with vitamin K

窒息早产儿凝血因子水平及其对维生素K的治疗反应观察

[ Objective ] To investigate the blood coagulation factor of asphyxia and to investigate the signification of the treatment to asphyxia preterm infant with vitamin K.

[目的]了解窒息早产儿凝血因子的水平，并通过对维生素K治疗前后凝血因子水平的比较，研究对窒息早产儿预防性应用维生素K的意义。

Human blood coagulation factor ⅶ( F ⅶ) is a vitamin K-dependent , single-chain glycoprotein that participates in the extrinsic phase of blood coagulation .

人凝血因子Ⅶ（FⅦ）是一种维生素K依赖的单链糖蛋白，在体内凝血过程中发挥着重要的作用。

The main distinguish between the two pathways are the difference of the startup mode and the blood coagulation factor involved , but they are not completely irrelevance to each other .

两条途径的主要区别在于启动方式和参加凝血因子不完全相同，但它们并不是各自完全独立的。

It is the most effective method that diagnosing DIC early , supplying blood coagulation factor in time , applying heparin selectively and small-doses as soon as possible and removing uterus pat timing .

早期诊断DIC、及时补充凝血因子，尽早选择性小剂量使用肝素适时切除子宫是抢救产科DIC的最有效方法。

Synthesis of a Chromogenic Substrate for Blood - coagulation Factor Xa

人血凝结因子Xa发色底物的合成研究

Genetic Analysis and Blood Assay of Coagulation Factor - IX Knockout Mouse Strain

凝血因子IX基因剔除小鼠的遗传及血液学指标检测

Study of Extraction of Three Porcine Coagulation Factors from the Blood of Pig and Coagulation Factor X Protein Analysis

猪血液中三种凝血因子的提取及凝血因子X的蛋白分析研究

Objective To investigate the relationship between Combined oral contraceptive ( COCs ) and blood coagulation factors changes and factor ⅴ Leiden mutation .

目的探讨国产复方口服避孕药（COC）与凝血因子的变化及因子V基因突变的关系。

Conclusion : It is the key of preventing DIC that expelling pathogeny in time , transfusing enough blood as soon as possible and supplying blood coagulation factor .

结论：及时去除病因，尽早足量输血并补充凝血因子是预防DIC的关键。